Quick Answer
Neurogene Inc. reported Total Assets of $288.60 million for fiscal year 2025.
Neurogene Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $288.60M | -14.0% |
| 2024 | $335.73M | +50.8% |
| 2023 | $222.57M | +103.7% |
| 2022 | $109.27M | -33.1% |
| 2021 | $163.26M | -22.4% |
| 2020 | $210.52M | +43.2% |
| 2019 | $147.02M | +89.4% |
| 2018 | $77.62M | -29.6% |
| 2017 | $110.33M | -28.5% |
| 2016 | $154.38M | +36.2% |
| 2015 | $113.34M | +173.6% |
| 2014 | $41.42M | +164.7% |
| 2013 | $15.65M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $287.83M | +75.4% | -3.2% |
| June 30, 2025 | $297.32M | +65.3% | -5.7% |
| March 31, 2025 | $315.30M | +61.4% | -6.1% |
| December 31, 2024 | $335.73M | +50.8% | +104.6% |
| September 30, 2024 | $164.12M | +83.2% | -8.7% |
| June 30, 2024 | $179.82M | +91.3% | -7.9% |
| March 31, 2024 | $195.35M | +98.4% | -12.2% |
| December 31, 2023 | $222.57M | +92.0% | +148.4% |
- Neurogene Inc. showed a decrease of -14.0% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Neurogene Inc.’s total assets has grown by 1744.2% (from $15.65 million to $288.60 million).
- The most recent figure is from Neurogene Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: